Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.

A hospital trust has become the first in the UK to fit patients with a new leadless pacemaker. Northampton General Hospital ...

Medical device manufacturer Medtronic (NYSE: MDT) is a healthcare industry stalwart. The company, based in the U.S. and ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...